1. Mulatero, P, Stowasser, M, Loh, K-C, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89: 1045–1050.
Google Scholar | Crossref | Medline | ISI2. Monticone, S, Burrello, J, Tizzani, D, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol 2017; 69: 1811–1820.
Google Scholar | Crossref | Medline | ISI3. Funder, JW. Primary aldosteronism: where are we now? where to from here? Horm Metab Res 2020; 52(6): 459–466.
Google Scholar | Crossref | Medline4. Young, WF Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J Intern Med 2019; 285: 126–148.
Google Scholar | Crossref | Medline5. Brooks, RV, Felix-Davies, D, Lee, MR, et al. Hyperaldosteronism from adrenal carcinoma. Br Med J 1972; 1: 220–221.
Google Scholar | Crossref | Medline6. Brown, JM, Siddiqui, M, Calhoun, DA, et al. The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Ann Intern Med 2020; 173: 10–20.
Google Scholar | Crossref | Medline7. Ito, Y, Takeda, R, Karashima, S, et al. Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects. Hypertens Res 2011; 34: 98–102.
Google Scholar | Crossref | Medline | ISI8. Nishikawa, T, Omura, M. Should primary aldosteronism be diagnosed among normotensive subjects during general health check-up and/or at general outpatient clinics? Hypertens Res 2011; 34: 47–48.
Google Scholar | Crossref | Medline9. Rossi, GP. Does primary aldosteronism exist in normotensive and mildly hypertensive patients, and should we look for it? Hypertens Res 2011; 34: 43–46.
Google Scholar | Crossref | Medline10. Karashima, S, Kometani, M, Tsujiguchi, H, et al. Prevalence of primary aldosteronism without hypertension in the general population: results in Shika study. Clin Exp Hypertens 2018; 40: 118–125.
Google Scholar | Crossref | Medline11. Médeau, V, Moreau, F, Trinquart, L, et al. Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases. Clin Endocrinol 2008; 69: 20–28.
Google Scholar | Crossref | Medline12. Markou, A, Pappa, T, Kaltsas, G, et al. Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension. J Clin Endocrinol Metab 2013; 98: 1409–1416.
Google Scholar | Crossref | Medline13. Kuroda, T, Okamura, K, Yoshinari, M, et al. A case of normotensive primary aldosteronism with hypopituitarism, epilepsy, and medullary sponge kidney. Acta Endocrinol (Copenh) 1989; 121: 797–801.
Google Scholar | Crossref | Medline14. Axelrod, L. Inhibition of prostacyclin production mediates permissive effect of glucocorticoids on vascular tone. Perturbations of this mechanism contribute to pathogenesis of Cushing’s syndrome and Addison’s disease. Lancet 1983; 1: 904–906.
Google Scholar | Crossref | Medline15. Scoggins, BA, Coghlan, JP, Denton, DA, et al. How do adrenocortical steroid hormones produce hypertension? Clin Exp Hypertens A 1984; 6: 315–328.
Google Scholar | Medline16. Beckers, A, Abs, R, Willems, PJ, et al. Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus. J Clin Endocrinol Metab 1992; 75: 564–570.
Google Scholar | Medline17. Demura, R, Naruse, M, Isawa, M, et al. A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion. Endocrinol Jpn 1992; 39: 169–176.
Google Scholar | Crossref | Medline18. Demura, M, Yoneda, T, Karashima, S, et al. A possible new syndrome with double endocrine tumors in association with an unprecedented type of familial heart-hand syndrome: a case report. J Med Case Rep 2010; 4: 347.
Google Scholar | Crossref | Medline19. Holland, OB, Gomez-Sanchez, CE, Kem, DC, et al. Evidence against prolactin stimulation of aldosterone in normal human subjects and patients with primary aldosteronism, including a patient with primary aldosteronism and a prolactin-producing pituitary microadenoma. J Clin Endocrinol Metab 1977; 45: 1064–1076.
Google Scholar | Crossref | Medline20. Gould, E, Albores-Saavedra, J, Shuman, J. Pituitary prolactinoma, pancreatic glucagonomas, and aldosterone-producing adrenal cortical adenoma: a suggested variant of multiple endocrine neoplasia type I. Hum Pathol 1987; 18: 1290–1293.
Google Scholar | Crossref | Medline21. Doumith, R, de Gennes, JL, Cabane, JP, et al. Pituitary prolactinoma, adrenal aldosterone-producing adenomas, gastric schwannoma and colonic polyadenomas: a possible variant of multiple endocrine neoplasia (MEN) type I. Acta Endocrinol (Copenh) 1982; 100: 189–195.
Google Scholar | Crossref | Medline22. Williams, TA, Dietz, AS, Theodoropoulou, M, et al. Coexisting prolactinoma and primary aldosteronism: is there a pathophysiological link? J Clin Endocrinol Metab 2015; 100: E1262–E1269.
Google Scholar | Crossref